Summit Creek Advisors LLC Bio Techne Corp Transaction History

Summit Creek Advisors LLC

  • $720 Million
  • Q3 2024

A detailed history of Summit Creek Advisors LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Summit Creek Advisors LLC holds 257,430 shares of TECH stock, worth $18.8 Million. This represents 2.86% of its overall portfolio holdings.

Number of Shares
257,430
Previous 250,489 2.77%
Holding current value
$18.8 Million
Previous $17.9 Million 14.62%
% of portfolio
2.86%
Previous 2.51%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$70.96 - $82.35 $492,533 - $571,591
6,941 Added 2.77%
257,430 $20.6 Million
Q2 2024

Aug 05, 2024
BUY
$62.12 - $84.15 $1.6 Million - $2.16 Million
25,726 Added 11.45%
250,489 $17.9 Million
Q1 2024

May 10, 2024
SELL
$65.98 - $77.09 $2.58 Million - $3.02 Million
-39,139 Reduced 14.83%
224,763 $15.8 Million
Q4 2023

Feb 07, 2024
BUY
$52.83 - $78.22 $13.9 Million - $20.6 Million
263,902 New
263,902 $20.4 Million
Q3 2023

Oct 30, 2023
BUY
$67.52 - $89.42 $66,709 - $88,346
988 Added 0.35%
284,681 $19.4 Million
Q2 2023

Aug 09, 2023
BUY
$73.76 - $85.98 $20,726 - $24,160
281 Added 0.1%
283,693 $23.2 Million
Q1 2023

May 05, 2023
BUY
$71.62 - $86.62 $1.58 Million - $1.91 Million
22,000 Added 8.42%
283,412 $21 Million
Q4 2022

Feb 10, 2023
BUY
$80.67 - $352.29 $16.2 Million - $71 Million
201,420 Added 335.74%
261,412 $21.7 Million
Q3 2022

Nov 01, 2022
BUY
$282.54 - $391.85 $522,699 - $724,922
1,850 Added 3.18%
59,992 $17 Million
Q2 2022

Aug 11, 2022
BUY
$322.67 - $449.65 $2,904 - $4,046
9 Added 0.02%
58,142 $20.2 Million
Q1 2022

May 09, 2022
BUY
$353.85 - $487.79 $61,569 - $84,875
174 Added 0.3%
58,133 $25.2 Million
Q4 2021

Feb 10, 2022
BUY
$456.15 - $525.06 $716,611 - $824,869
1,571 Added 2.79%
57,959 $30 Million
Q3 2021

Nov 08, 2021
BUY
$444.87 - $538.88 $2.02 Million - $2.45 Million
4,538 Added 8.75%
56,388 $27.3 Million
Q2 2021

Aug 04, 2021
SELL
$387.35 - $450.26 $4.21 Million - $4.9 Million
-10,880 Reduced 17.34%
51,850 $23.3 Million
Q1 2021

Apr 20, 2021
SELL
$314.62 - $411.0 $455,884 - $595,539
-1,449 Reduced 2.26%
62,730 $24 Million
Q4 2020

Jan 20, 2021
BUY
$246.9 - $321.87 $224,679 - $292,901
910 Added 1.44%
64,179 $20.4 Million
Q3 2020

Oct 14, 2020
SELL
$232.22 - $282.96 $1.37 Million - $1.66 Million
-5,880 Reduced 8.5%
63,269 $15.7 Million
Q2 2020

Jul 15, 2020
SELL
$185.43 - $279.56 $3.35 Million - $5.05 Million
-18,060 Reduced 20.71%
69,149 $18.3 Million
Q1 2020

Apr 27, 2020
BUY
$161.17 - $221.51 $809,073 - $1.11 Million
5,020 Added 6.11%
87,209 $16.5 Million
Q4 2019

Jan 17, 2020
SELL
$189.68 - $222.09 $89,149 - $104,382
-470 Reduced 0.57%
82,189 $18 Million
Q3 2019

Oct 16, 2019
BUY
$183.56 - $216.72 $706,706 - $834,372
3,850 Added 4.89%
82,659 $16.2 Million
Q2 2019

Jul 19, 2019
BUY
$188.72 - $215.43 $43,405 - $49,548
230 Added 0.29%
78,809 $16.4 Million
Q1 2019

Apr 15, 2019
SELL
$136.09 - $200.44 $19,052 - $28,061
-140 Reduced 0.18%
78,579 $15.6 Million
Q4 2018

Jan 15, 2019
SELL
$132.75 - $203.8 $373,027 - $572,678
-2,810 Reduced 3.45%
78,719 $11.4 Million
Q3 2018

Oct 11, 2018
SELL
$147.44 - $204.11 $4.09 Million - $5.67 Million
-27,760 Reduced 25.4%
81,529 $16.6 Million
Q2 2018

Jul 17, 2018
SELL
$144.9 - $165.58 $1.47 Million - $1.68 Million
-10,130 Reduced 8.48%
109,289 $16.2 Million
Q1 2018

Apr 16, 2018
BUY
$131.46 - $151.04 $1.79 Million - $2.06 Million
13,637 Added 12.89%
119,419 $18 Million
Q4 2017

Jan 16, 2018
SELL
$121.17 - $134.75 $89,059 - $99,041
-735 Reduced 0.69%
105,782 $13.7 Million
Q3 2017

Oct 17, 2017
BUY
$113.59 - $123.78 $12.1 Million - $13.2 Million
106,517
106,517 $12.9 Million

Others Institutions Holding TECH

# of Institutions
602
Shares Held
151M
Call Options Held
195K
Put Options Held
53.2K
View Full List

About BIO-TECHNE Corp

TECH Quotes by TradingView
  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.87B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Summit Creek Advisors LLC Portfolio

Follow Summit Creek Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Creek Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Creek Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email